Market Outlook

By 2035, the U.S. Handheld Surgical Instruments Market is projected to reach approximately USD 5.05 billion, expanding at a CAGR of 7.50% during the forecast period 2026–2035. The market is estimated at approximately USD 2.45 billion in 2025, following historical expansion from around USD 1.86 billion in 2021, USD 1.98 billion in 2022, USD 2.12 billion in 2023, and USD 2.30 billion in 2024. Values in this report are expressed in USD billions.

The market sizing represents a U.S.-specific syndicate estimate developed through a combination of global-to-U.S. revenue allocation, surgical procedure intensity, installed healthcare infrastructure, reusable instrument replacement cycles, specialty-level instrument requirements, ambulatory surgery migration, procurement trends, and manufacturer portfolio positioning. As a cross-check, the global hand-held surgical instruments market was valued at approximately USD 6.2 billion in 2024, with North America accounting for 40.6% of global revenue, supporting a U.S. market opportunity above USD 2 billion before accounting for 2025 procedure growth and product replacement.

For this report, handheld surgical instruments include manually operated instruments used for cutting, dissecting, grasping, clamping, retracting, suturing, probing, dilation, tissue manipulation, curettage, and related surgical tasks. The market includes forceps, graspers, clamps, scissors, retractors, scalpels and surgical knives, needle holders, dilators, probes, curettes, dissectors, elevators, osteotomes, rongeurs, specialty micro-instruments, and comparable reusable or sterile single-use products. Powered surgical equipment, robotic systems, endoscopes, electrosurgical generators, implants, capital operating-room equipment, and automated surgical platforms are excluded unless the product is primarily a manually controlled handheld instrument.

The market is structurally attractive because handheld instruments remain indispensable even as U.S. operating rooms adopt robotics, advanced visualization, image guidance, and minimally invasive platforms. Open procedures require extensive instrument inventories, but robotic and laparoscopic procedures also depend on manual instruments for access, exposure, suturing, specimen management, conversion readiness, vascular control, and procedural support. As a result, technology adoption changes the composition of the instrument tray rather than eliminating demand.

Another important feature is the combination of durable and recurring revenue. Premium stainless-steel and titanium instruments can remain in service through repeated sterilization cycles, but hospitals continuously replace instruments because of jaw misalignment, dull cutting surfaces, corrosion, damaged ratchets, insulation deterioration, lost instruments, surgeon preference changes, new procedural programs, and tray standardization initiatives. At the same time, sterile single-use instruments provide recurring revenue in ambulatory, office-based, specialty, infection-sensitive, and low-volume surgical environments.

The addressable care infrastructure is extensive. U.S. hospitals collectively maintain approximately 907,000 staffed beds and record more than 35.6 million annual admissions, while Medicare outpatient payment policies affect approximately 6,000 ambulatory surgery centers. These settings create a broad installed base requiring instrument sets, sterile-processing support, maintenance, replacement, inventory optimization, and procedural expansion.

Through 2035, value creation will increasingly favor suppliers that move beyond individual instrument sales. Manufacturers able to combine instrument breadth, specialty expertise, repair services, tray optimization, traceability, sterile-processing support, guaranteed availability, clinician education, and enterprise contracting will gain stronger access to integrated delivery networks. Consequently, competition will increasingly center on total instrument lifecycle economics, rather than acquisition price alone.

 

Introduction

According to the U.S. Handheld Surgical Instruments Market Report, the category represents one of the most foundational elements of the American surgical ecosystem. Although individual forceps, scissors, retractors, clamps, or needle holders typically attract less strategic attention than robotic platforms or high-value implants, the functionality of almost every operating room depends on the availability of reliable manual instruments in the correct configuration, condition, and quantity.

The economic relevance of these products is amplified by procedure volume. Historical federal data identified approximately 14.4 million operating-room procedures across 9.6 million U.S. inpatient stays involving an OR procedure in 2018, with those hospitalizations accounting for USD 210.3 billion in aggregate hospital costs. Surgical care has also been estimated to represent nearly one-third of U.S. healthcare spending. Although these data precede the current forecast period, they demonstrate the underlying scale of the procedural environment into which handheld instruments are consumed and reprocessed.

The U.S. surgical environment has subsequently become more outpatient-oriented. Approximately 6,000 ASCs are now directly affected by Medicare ASC payment policy, creating a large non-hospital channel where efficient instrument utilization is particularly important. ASCs operate under tighter procedure-level economics than large hospitals and typically cannot carry the same redundant instrument inventory. They therefore favor standardized sets, rapid turnover, reliable reusable instruments, sterile single-use products for selected procedures, and suppliers capable of fast replenishment.

Demographics reinforce the demand profile. The U.S. population aged 65 and older reached approximately 61.2 million in 2024, representing 18.0% of the population. Older patients generate disproportionate demand for orthopedic reconstruction, cataract procedures, oncologic surgery, cardiovascular procedures, urologic intervention, spinal surgery, and other instrument-intensive specialties.

The market is also highly fragmented at the individual SKU level. Major manufacturers can offer thousands or even tens of thousands of instrument patterns. For example, established U.S. suppliers market portfolios exceeding 17,000 surgical instrument products or patterns, reflecting differences in tip geometry, jaw design, curvature, handle length, working length, specialty requirements, surgeon preference, and procedural approach.

This fragmentation makes hospital purchasing considerably more complex than simply selecting a vendor. Procurement leaders must determine which instruments can be standardized, which surgeon-specific instruments must be preserved, whether existing trays contain unnecessary items, which products can be repaired instead of replaced, and where disposable alternatives create better economics. For manufacturers, commercial success therefore depends on understanding clinical workflow as deeply as instrument metallurgy.

From 2026 through 2035, the U.S. market will increasingly differentiate between commodity instrumentation and high-value procedural instrumentation. Standard forceps and scissors will remain price-sensitive, while microsurgical tools, cardiovascular instruments, specialty retractors, orthopedic instruments, titanium products, tungsten-carbide cutting instruments, minimally invasive designs, and customized procedural sets will sustain stronger pricing power.

 

Key Market Drivers: What’s Fueling the U.S. Handheld Surgical Instruments Market Boom?

The first major driver is the large and resilient U.S. surgical procedure base. Handheld instruments participate across general surgery, orthopedics, neurosurgery, cardiovascular surgery, obstetrics and gynecology, urology, ENT, ophthalmology, plastic surgery, trauma, oncology, and numerous subspecialties. Unlike technologies dependent on a narrow procedure indication, manual surgical instruments are diversified across virtually every operating-room service line. This reduces category-level volatility when procedure trends shift between specialties.

The second driver is population aging and rising surgical complexity. Approximately 61.2 million Americans were aged 65 years or older in 2024, and this population continues to expand. Older patients typically present with multiple comorbidities, previous procedures, altered anatomy, degenerative disease, cancer, cardiovascular disease, and musculoskeletal conditions. These factors increase demand not only for surgical procedures but also for specialized instrumentation capable of handling complex anatomy and tissue conditions.

Cancer represents another durable surgical demand driver. More than 2.04 million new cancer cases were estimated in the United States for 2025, including approximately 319,750 breast cancers, 313,780 prostate cancers, 226,650 lung cancers, and 154,270 colorectal cancers. Surgical intervention remains important across many solid tumors, supporting recurring use of retractors, clamps, dissectors, forceps, scissors, needle holders, specialty oncology instruments, and minimally invasive hand tools.

The third major driver is the expansion of ambulatory surgery. Procedures that historically required inpatient hospitalization increasingly migrate to hospital outpatient departments and independent ASCs when clinically appropriate. CMS payment policies for 2026 affect approximately 4,000 hospitals and approximately 6,000 ASCs, highlighting the scale of this outpatient infrastructure. For instrument manufacturers, ASC expansion creates demand for compact procedure-specific sets, faster replenishment, standardized configurations, economical reusable instruments, and sterile single-use options that simplify workflow.

The fourth driver is replacement and lifecycle demand within existing instrument fleets. Reusable surgical instruments may survive hundreds of cycles when correctly maintained, but repeated cleaning, disinfection, sterilization, transport, mechanical stress, and handling gradually affect performance. Cutting instruments become dull, box locks loosen, ratchets lose alignment, fine forceps tips deform, coatings deteriorate, and specialty instruments may be lost or damaged. Because surgical teams cannot tolerate unreliable instrumentation during procedures, replacement demand persists even without increases in procedure volume.

Reprocessing economics are therefore becoming integral to procurement. The FDA classifies reusable surgical forceps as critical devices because they contact blood or normally sterile tissue. Reprocessing requires cleaning followed by appropriate disinfection or sterilization, and inadequate processing can leave tissue or microorganisms on devices. Manufacturers that design instruments for easier cleaning, validated reprocessing, reduced crevice contamination, durability, and clear instructions for use can offer measurable lifecycle advantages.

The fifth driver is hospital instrument-set rationalization. U.S. health systems increasingly analyze whether surgical trays contain instruments that are rarely used but must still be counted, transported, cleaned, inspected, packaged, and sterilized after every case. Removing unnecessary instruments can reduce sterile-processing labor, tray weight, sterilization capacity requirements, and replacement exposure. This dynamic does not necessarily reduce market value. It redirects spending toward higher-utilization instruments, standardized replacements, optimized sets, and vendor-supported lifecycle programs.

The sixth driver is surgeon preference and procedural specialization. Handheld instruments remain highly tactile products. Jaw feel, handle balance, spring resistance, cutting quality, grip geometry, shaft length, tip profile, and weight can materially affect clinician preference. This creates defensibility for established premium brands, particularly in cardiovascular, neuro, orthopedic, microsurgery, ENT, ophthalmology, and reconstructive applications where small design differences influence procedural confidence.

The seventh driver is infection-control pressure and sterile-processing capacity. Sterile processing departments are increasingly expected to manage large instrument inventories while controlling labor cost, turnaround time, instrument integrity, and compliance. FDA guidance emphasizes that reusable-device reprocessing is detailed, multistep, labor-intensive, and specific to the instrument. These operational burdens support investment in easier-to-process reusable designs and selective migration toward single-use instruments where the economics are favorable.

Finally, the market benefits from a regulatory framework in which many conventional manual surgical instruments are established device types. General surgical forceps and scissors, for example, are typically regulated as Class I manual surgical instruments under 21 CFR 878.4800 and can be 510(k)-exempt subject to applicable limitations and regulatory requirements. This lowers certain barriers to portfolio expansion compared with highly complex implantable technologies, although manufacturers remain responsible for quality-system, registration, labeling, complaint, and applicable manufacturing obligations.

 

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in handheld surgical instruments is less visible than robotic innovation, but commercially meaningful improvements continue across ergonomics, metallurgy, reprocessing, traceability, specialty design, and procedural workflow.

Ergonomic engineering is receiving greater attention because surgeons may repeatedly manipulate instruments during procedures lasting several hours. Manufacturers are refining handle geometry, finger-ring size, spring resistance, instrument balance, grip texture, and shaft weight to reduce fatigue. Ergonomics can become particularly important in microsurgery, cardiovascular surgery, neuro procedures, reconstructive surgery, and minimally invasive operations where fine control is required.

Materials innovation is another competitive dimension. Medical-grade stainless steel remains dominant because it provides an attractive combination of strength, manufacturability, corrosion resistance, sterilization compatibility, and cost. Titanium is strategically important for lightweight instruments and specialties requiring low mass, corrosion resistance, or reduced magnetic properties. Tungsten-carbide inserts are used in selected scissors and needle holders where cutting durability or grip retention justifies premium pricing.

Surface treatment is also evolving. Satin and non-reflective finishes can reduce glare under high-intensity operating lights. Advanced passivation and surface engineering support corrosion resistance, while specialized coatings may improve hardness or visual differentiation. For buyers, however, coatings must demonstrate durability across repeated cleaning and sterilization cycles; aesthetic differentiation without lifecycle performance offers limited value.

Minimally invasive handheld instrumentation is an important premium growth area. Traditional hand-controlled instruments are being redesigned with longer shafts, narrower profiles, atraumatic jaws, angled tips, articulating mechanisms, dual-pivot configurations, and improved access for smaller incisions. This allows conventional tactile control to coexist with minimally invasive workflows. Specialty thoracic instrumentation illustrates this trend, where instruments can combine traditional handles with geometries designed for small-incision access.

Single-use sterile instruments represent another innovation cycle. Disposable forceps, scissors, scalpels, retractors, and procedure-specific instruments eliminate reprocessing requirements and provide predictable first-use sharpness or functionality. They are especially attractive when procedural frequency is low, reprocessing is operationally difficult, infection-control requirements are strict, or the economic cost of maintaining reusable inventory exceeds the unit cost of sterile supply. Reusable instruments will remain dominant by value, but hybrid procurement models will become more common.

Instrument identification and traceability are also gaining importance. Laser marking, machine-readable identification, tray-level tracking, and digital sterile-processing systems can help hospitals understand instrument location, utilization, repair history, sterilization cycles, and loss patterns. Over time, procurement teams will increasingly use these data to determine which instruments require replacement and which trays can be redesigned.

Innovation is also moving toward instrument-service ecosystems. Manufacturers and specialty service providers increasingly compete on sharpening, alignment, repair, refurbishment, tray assessment, instrument identification, and replacement programs. This service layer can improve customer retention because hospitals generally prefer predictable instrument availability to repeated emergency purchasing.

The regulatory environment is simultaneously becoming more quality-system focused. The FDA’s Quality Management System Regulation became effective on February 2, 2026, incorporating ISO 13485:2016 into the U.S. device quality framework. For handheld-instrument manufacturers, particularly suppliers with international production networks, stronger quality-system harmonization increases the strategic importance of supplier control, process validation, complaint handling, risk management, and manufacturing consistency.

 

Segmentation Insights

The U.S. Handheld Surgical Instruments Market is segmented on the basis of product type, application, usability, material and construction, and end user.

 

By Product Type

Forceps and Graspers

Forceps and graspers represent the largest individual product category, accounting for an estimated USD 0.59 billion of U.S. revenue in 2025. The segment includes tissue forceps, dressing forceps, vascular forceps, dissecting forceps, atraumatic forceps, micro-forceps, laparoscopic graspers, and specialty designs. Demand is broad because tissue handling is required across almost every surgical specialty.

Premium growth is concentrated in atraumatic cardiovascular designs, microsurgical forceps, fine ophthalmic and neuro instrumentation, minimally invasive graspers, and titanium products. Commodity general-purpose forceps remain highly price competitive, making manufacturing consistency and distribution efficiency essential.

Retractors

Retractors generated approximately USD 0.46 billion in 2025 and represent a strategically important category because exposure is fundamental to open and limited-incision surgery. The segment includes handheld retractors, self-retaining retractors, abdominal retractors, orthopedic retractors, spinal retractors, vascular retractors, neurosurgical designs, and specialty exposure systems.

Demand is particularly strong in orthopedics, spine, general surgery, cardiovascular surgery, plastic surgery, and gynecology. Growth is moving toward procedure-specific designs that provide better visualization through smaller incisions and reduce the need for additional surgical assistance.

Surgical Scissors

Surgical scissors account for an estimated USD 0.37 billion in 2025. The category includes operating scissors, dissecting scissors, vascular scissors, suture scissors, micro-scissors, ophthalmic scissors, and specialty angled designs. Performance is determined by blade geometry, edge retention, alignment, handling characteristics, and resistance to degradation during repeated reprocessing.

Reusable premium scissors maintain strong demand in hospitals, while sterile disposable scissors are gaining penetration in outpatient and procedural settings. Tungsten-carbide and precision-cutting products command higher pricing when durability can offset replacement and sharpening costs.

Clamps and Occluding Instruments

Clamps represent approximately USD 0.34 billion of the 2025 U.S. market. Hemostatic clamps, vascular clamps, bowel clamps, towel clamps, bulldog clamps, and specialty occluding devices are essential for controlling tissue, vessels, tubing, and operative fields.

Cardiovascular and thoracic applications support premium pricing because atraumatic closure and precise force distribution are critical. General hemostatic clamps have a more mature demand profile but benefit from broad utilization and regular replacement.

Scalpels and Surgical Knives

Scalpels, reusable knife handles, and specialty manually controlled cutting instruments generated approximately USD 0.24 billion in 2025. The category is mature but benefits from enormous procedure frequency. Single-use sterile blades dominate recurring consumption, while reusable handles remain embedded across operating rooms and procedure suites.

Specialty ophthalmic, ENT, reconstructive, dermatologic, and microsurgical knives add premium value despite smaller unit volumes.

Needle Holders

Needle holders represent approximately USD 0.22 billion in 2025 revenue. Demand is closely linked to suturing requirements in open surgery, microsurgery, cardiovascular procedures, reconstruction, OB/GYN, and general surgery. Premium instruments incorporate fine jaw patterns, tungsten-carbide inserts, lightweight construction, and specialty handle mechanisms.

Despite increasing use of stapling and robotic suturing in selected procedures, conventional needle holders remain indispensable during open, hybrid, emergency, conversion, and specialty procedures.

Dilators, Probes, Curettes, Dissectors and Other Instruments

The remaining product group accounts for roughly USD 0.23 billion and includes dilators, probes, curettes, elevators, osteotomes, rongeurs, dissectors, hooks, spatulas, punches, measuring devices, and specialty manual instruments. Revenue is fragmented across clinical specialties, but individual categories can command attractive margins because precise designs are often difficult to substitute.

 

By Application

General and Abdominal Surgery

General surgery is the largest application, representing approximately 23% of U.S. handheld instrument revenue in 2025. Cholecystectomy, hernia repair, colorectal surgery, appendectomy, gastrointestinal procedures, bariatric surgery, breast surgery, endocrine procedures, and emergency abdominal operations require extensive manual instrument support.

Although laparoscopy and robotics continue to expand, conventional handheld instruments remain necessary for access, incision management, tissue exposure, dissection, specimen handling, closure, and contingency conversion to open surgery.

Orthopedic and Spine Surgery

Orthopedic and spine procedures represent approximately 20% of the 2025 market and are particularly instrument intensive. Retractors, rongeurs, osteotomes, curettes, elevators, clamps, reduction instruments, probes, forceps, and specialty cutting tools are used across joint reconstruction, trauma, sports medicine, extremity procedures, spinal decompression, fusion, and deformity correction.

The segment benefits from the aging population and high U.S. orthopedic procedure volumes. Instrument wear can be significant because products interact with bone, implants, and high mechanical forces, creating stronger replacement demand than in many soft-tissue specialties.

Cardiovascular and Thoracic Surgery

Cardiovascular and thoracic surgery accounts for approximately 12% of 2025 revenue, but its value share exceeds its unit share because the category relies heavily on precision instruments. Vascular clamps, DeBakey-pattern forceps, fine scissors, needle holders, rib and thoracic retractors, minimally invasive cardiac instruments, and microsurgical tools support premium pricing.

Demand is shifting as selected cardiovascular procedures become catheter based. However, cardiac surgery, vascular reconstruction, transplant procedures, thoracic oncology, and complex hybrid interventions continue to require high-quality handheld instrumentation.

Neurosurgery

Neurosurgery contributes approximately 10% of market revenue. Fine tissue handling, restricted anatomical access, delicate neural structures, and long procedures create demand for lightweight and highly precise forceps, dissectors, scissors, curettes, rongeurs, retractors, micro-instruments, and specialty instruments.

Purchasing decisions are heavily surgeon influenced. Titanium construction, microsurgical designs, balance, tip alignment, and low-glare finishes can justify significant price premiums.

Obstetrics and Gynecology

OB/GYN accounts for approximately 11% of market revenue, supported by cesarean delivery, hysterectomy, gynecologic oncology, pelvic procedures, fertility-related procedures, and other interventions. The U.S. recorded approximately 3.63 million births in 2024, and the national cesarean delivery rate was approximately 32.4%, demonstrating a substantial recurring surgical workload.

Retractors, clamps, scissors, forceps, needle holders, uterine instruments, dilators, curettes, speculums, and minimally invasive gynecologic instruments therefore constitute a durable demand base.

Urology

Urology represents approximately 9% of 2025 revenue, supported by prostate, bladder, renal, reconstructive, oncologic, and pelvic procedures. Instrument demand spans open and minimally invasive workflows. The growing older male population and substantial incidence of prostate and bladder cancer support procedure activity over the forecast period.

Ophthalmology, ENT, Plastic and Reconstructive Surgery

These specialties collectively account for approximately 15% of the market. Although individual instruments are smaller, they often require exceptional precision and can command high prices. Ophthalmic micro-forceps, scissors and knives, ENT elevators and speculums, reconstructive instruments, and delicate plastic-surgery forceps and needle holders contribute materially to premium instrument revenue.

 

By Usability

Reusable Handheld Instruments

Reusable instruments dominate the U.S. market, representing approximately 74% of 2025 revenue, or around USD 1.81 billion. Their economic advantage is strongest in high-volume hospital procedures where repeated utilization can distribute acquisition cost across hundreds of cases.

The central purchasing question, however, is increasingly total lifecycle cost. Hospitals must account for cleaning, inspection, repair, sterilization, instrument loss, tray assembly, inventory duplication, and sterile-processing labor. Manufacturers capable of reducing these costs can retain premium positioning even when their initial instrument price is higher.

Single-Use and Sterile Disposable Instruments

Single-use instruments account for approximately 26%, or USD 0.64 billion, and are expected to grow faster than reusable products through 2035. Adoption is strongest where reprocessing economics are unfavorable, contamination control is especially important, procedure volume is low, or predictable first-use functionality is valued.

The segment is unlikely to displace reusable instruments across major hospital ORs. Instead, the U.S. market will evolve toward hybrid models in which health systems deliberately select reusable or disposable products based on case volume, specialty, sterile-processing capacity, sustainability objectives, and procedure economics.

 

By Material and Construction

Stainless Steel Instruments

Medical-grade stainless steel accounts for approximately 78% of 2025 revenue and will remain the dominant material through 2035. Its balance of strength, corrosion resistance, manufacturability, sterilization tolerance, availability, and cost makes it suitable for most manual surgical instruments.

Differentiation within stainless-steel products depends on alloy quality, heat treatment, machining precision, surface finish, joint construction, polishing, and final inspection rather than the basic material alone.

Titanium Instruments

Titanium accounts for approximately 10% of market value. It is particularly relevant for microsurgical, neuro, ophthalmic, cardiovascular, reconstructive, and specialty instruments where lower weight can improve handling during long procedures. Its premium price restricts mass-market penetration but supports strong value contribution.

Tungsten-Carbide, Ceramic-Inserted and Premium Hybrid Instruments

Approximately 7% of market revenue is attributable to tungsten-carbide inserted, ceramic-enhanced, and related premium constructions. Tungsten-carbide inserts are particularly established in needle holders and surgical scissors because they can improve gripping or cutting durability.

Polymer, Composite and Other Hybrid Instruments

Polymer and composite constructions represent approximately 5% of the market and are more strongly associated with single-use or specialty instruments. Their role is expected to increase as manufacturers pursue lighter devices, simplified sterile manufacturing, differentiated gripping surfaces, and procedure-specific disposable products.

 

By End User

Hospitals and Integrated Health Systems

Hospitals and integrated delivery networks represent approximately 62% of 2025 market revenue, equivalent to about USD 1.52 billion. Their leadership reflects high procedural acuity, broad specialty coverage, large reusable instrument fleets, trauma requirements, teaching activity, and complex operating-room infrastructure.

Large systems increasingly negotiate enterprise contracts instead of allowing every facility to purchase independently. Vendors that can supply multiple specialties, provide instrument repair, support conversion between brands, standardize trays, and guarantee supply continuity hold a strategic advantage.

Ambulatory Surgery Centers

ASCs represent approximately 24% of the market, or nearly USD 0.59 billion, and are expected to gain share through 2035. Approximately 6,000 ASCs are affected by current Medicare payment policies, illustrating the size of the channel.

ASC buyers prioritize economic simplicity. They require smaller inventories, dependable procedure-specific sets, rapid turnover, minimal downtime, and lower working capital. This creates strong opportunities for mid-priced reusable portfolios and sterile single-use instruments.

Specialty Surgical Centers and Physician-Based Procedure Facilities

Specialty centers, office surgical practices, ophthalmology clinics, dermatology practices, dental and maxillofacial centers, plastic surgery facilities, and other procedural clinics account for approximately 9% of market revenue. These buyers frequently have narrower procedure profiles and can therefore standardize instruments more aggressively than large hospitals.

Government, Veterans, Military and Other Institutional Providers

Government and other institutional providers account for approximately 5% of the market. Procurement is often contract driven and places significant importance on product durability, standardized specifications, reliable distribution, regulatory compliance, and lifecycle value.

 

Regional Insights: Where the Market is Growing Fastest

The U.S. Handheld Surgical Instruments Market is geographically segmented into the South, West, Northeast, and Midwest. Regional demand varies according to population growth, age structure, procedure density, hospital and ASC concentration, specialty-care infrastructure, surgeon availability, payer mix, health-system consolidation, and the pace of outpatient surgery migration.

The South is estimated to lead the market with approximately USD 0.89 billion in 2025, followed by the Northeast at USD 0.57 billion, the West at USD 0.55 billion, and the Midwest at USD 0.44 billion. By 2035, the regional opportunity is projected to reach approximately USD 1.86 billion in the South, USD 1.22 billion in the West, USD 1.11 billion in the Northeast, and USD 0.86 billion in the Midwest.

South

The South represents approximately 36% of the U.S. market in 2025 and is projected to remain the largest regional opportunity through 2035. Population scale, rapid migration into major metropolitan areas, a large Medicare population, strong ASC development, and significant orthopedic, general, cardiovascular, OB/GYN, oncology, and trauma workloads support instrument consumption.

The regional analysis covers Texas, Florida, Georgia, North Carolina, South Carolina, Virginia, West Virginia, Maryland, Delaware, Kentucky, Tennessee, Alabama, Mississippi, Arkansas, Louisiana, Oklahoma, and the District of Columbia.

Texas is the largest state opportunity in the region because of its population scale, major hospital networks, extensive suburban surgical infrastructure, trauma burden, orthopedic demand, cardiovascular programs, and rapidly growing metropolitan areas. Houston, Dallas-Fort Worth, Austin, and San Antonio collectively create one of the country’s most important surgical procurement corridors.

Florida combines population scale with one of the country’s largest older-adult populations. Demand is particularly strong for orthopedic, ophthalmic, cardiovascular, oncology, urology, and general surgical instrumentation. Its extensive ambulatory surgery ecosystem makes the state especially attractive for suppliers offering both reusable and sterile single-use portfolios.

North Carolina, Georgia, Virginia, and Tennessee represent substantial growth markets because of expanding metropolitan populations, strong referral networks, academic medicine, and rising surgical capacity. North Carolina has particularly attractive orthopedics, neuro, general surgery, and research-oriented demand, while Georgia and Tennessee provide large regional referral hubs.

South Carolina, Kentucky, Alabama, Mississippi, Louisiana, Arkansas, Oklahoma, and West Virginia are smaller by absolute market size but maintain meaningful demand from chronic disease, trauma, cardiovascular surgery, orthopedic procedures, and general surgery. High cesarean-delivery rates in several Southern states also create consistent OB/GYN instrumentation requirements. For example, 2024 cesarean rates were approximately 37.9% in Mississippi, 36.3% in Louisiana, 36.3% in Florida, 35.1% in West Virginia, and 34.5% in Texas.

Maryland, Delaware, Virginia, and the District of Columbia benefit from sophisticated health systems, academic centers, federal healthcare activity, and strong specialty-surgery intensity.

The South is projected to expand from USD 0.89 billion in 2025 to approximately USD 1.86 billion by 2035, representing a CAGR of roughly 7.65%. The fastest commercial opportunities will occur around rapidly growing metropolitan markets where hospitals and ASCs are simultaneously expanding capacity.

West

The West represented approximately USD 0.55 billion in 2025 and is expected to be the fastest-growing U.S. region, reaching approximately USD 1.22 billion by 2035, equivalent to an estimated CAGR of about 8.29%.

The region includes California, Washington, Oregon, Arizona, Nevada, Colorado, Utah, New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii.

California is the dominant Western state market and one of the largest handheld surgical instrument markets nationally. Its combination of population size, advanced academic medicine, ambulatory surgery penetration, specialty hospitals, cancer programs, reconstructive surgery, orthopedics, cardiovascular care, and medtech innovation supports substantial premium-instrument demand. California buyers also tend to adopt data-driven sterile-processing optimization and sustainability initiatives earlier than many other states.

Arizona and Nevada are important growth markets because of rapid population expansion and increasing older-adult populations. Orthopedic reconstruction, spine, ophthalmology, general surgery, and cardiovascular procedures are particularly relevant to instrument demand.

Washington, Oregon, Colorado, and Utah have sophisticated integrated health systems and comparatively strong adoption of standardized procurement, outpatient surgery, minimally invasive workflows, and digital instrument management. Manufacturers able to combine premium instruments with lifecycle management services can perform well in these markets.

Idaho, Montana, Wyoming, New Mexico, Alaska, and Hawaii represent smaller state opportunities but have distinctive procurement requirements. Geographic dispersion increases the value of product durability, inventory availability, simplified trays, and dependable distribution. Rural and remote providers cannot tolerate lengthy replacement delays for essential instruments.

The West’s above-market growth will be driven by demographic expansion, ASC investment, specialty surgery development, advanced minimally invasive procedures, and early adoption of premium ergonomic and digitally traceable instrument portfolios.

Northeast

The Northeast generated approximately USD 0.57 billion in 2025 and is projected to reach around USD 1.11 billion by 2035, representing an estimated CAGR of 6.89%.

The region includes New York, Pennsylvania, New Jersey, Massachusetts, Connecticut, Rhode Island, Maine, New Hampshire, and Vermont.

New York is the largest Northeast market. High hospital density, major surgical referral centers, extensive cancer care, transplant programs, cardiovascular surgery, neurosurgery, orthopedics, and a large outpatient environment create significant demand across both standard and premium instruments.

Pennsylvania and New Jersey provide large general-surgery, orthopedic, cardiovascular, neurosurgical, and ASC markets. Their dense healthcare networks and proximity to major metropolitan areas make them important targets for enterprise purchasing agreements.

Massachusetts has disproportionate strategic importance relative to its population because of advanced academic surgery, medical technology research, clinical trials, transplant programs, cardiovascular care, neurosurgery, and complex tertiary procedures. Premium instrument suppliers frequently benefit from clinician-led product evaluation and demand for specialist instrumentation.

Connecticut and Rhode Island are smaller but high-value markets with mature hospital infrastructure, while Maine, New Hampshire, and Vermont provide lower-volume opportunities where durability, repair programs, efficient inventory management, and reliable distribution are important.

The Northeast is more mature than the South and West, which limits volume-driven expansion. However, high procedural complexity and specialist density support attractive average selling prices and premium instrument adoption.

Midwest

The Midwest accounted for approximately USD 0.44 billion in 2025 and is projected to reach approximately USD 0.86 billion by 2035, corresponding to an estimated CAGR near 6.93%.

The region includes Illinois, Ohio, Michigan, Indiana, Wisconsin, Minnesota, Missouri, Iowa, Kansas, Nebraska, North Dakota, and South Dakota.

Illinois, Ohio, Michigan, and Minnesota are the most strategically important state markets. Chicago supports a dense surgical ecosystem spanning academic medicine, orthopedics, cardiovascular care, oncology, trauma, and outpatient surgery. Ohio contains major referral programs and large hospital networks that create significant instrument-standardization opportunities.

Michigan maintains substantial orthopedic, cardiovascular, general surgical, and specialty-care demand. Minnesota combines high-quality healthcare delivery with a prominent medical-device ecosystem, making it an influential market for instrument innovation, clinician feedback, and specialty procurement.

Indiana, Wisconsin, and Missouri provide stable procedure volumes across community hospitals, regional referral centers, and ambulatory facilities. Cost-effectiveness and instrument lifecycle performance are particularly important purchasing factors.

Iowa, Kansas, Nebraska, North Dakota, and South Dakota have smaller populations and more geographically dispersed care delivery. Hospitals in these states often prioritize durable reusable instruments, standardized trays, service responsiveness, and dependable access to replacement products.

The Midwest is unlikely to outgrow the West or South but provides manufacturers with a stable revenue base characterized by established surgical volumes, integrated health systems, orthopedic demand, and long-term customer relationships.

 

Key Market Players

Competition in the U.S. Handheld Surgical Instruments Market is fragmented but highly structured. Large global medical-device companies compete with specialized surgical-instrument manufacturers, hospital-supply companies, specialty distributors, and premium niche brands.

Portfolio breadth is important, but breadth alone is insufficient. Competitive differentiation increasingly depends on manufacturing consistency, metallurgy, specialty patterns, surgeon relationships, repair capabilities, tray optimization, instrument availability, sterile-processing knowledge, contract flexibility, and the ability to support enterprise health systems.

Some of the key players operating in or serving the U.S. handheld surgical instruments market include:

B. Braun / Aesculap
STERIS – V. Mueller and Snowden-Pencer
Integra LifeSciences / Integra Miltex
Aspen Surgical / Symmetry Surgical
Sklar Corporation
KLS Martin Group
Medline Industries
Johnson & Johnson MedTech / Ethicon
Teleflex Incorporated
Stryker Corporation
Zimmer Biomet
CONMED Corporation
Arthrex
CooperSurgical
Olympus Corporation
KARL STORZ
Scanlan International
Thompson Surgical Instruments
STILLE
gSource
Millennium Surgical
Boss Instruments
Surgical Holdings
Surtex Instruments

The competitive hierarchy varies substantially by specialty. B. Braun/Aesculap, STERIS, Integra, Sklar, Medline, KLS Martin, and Aspen/Symmetry have broad relevance in conventional manual instrumentation. Specialty suppliers such as Scanlan are influential in cardiovascular, thoracic, and minimally invasive instruments. Orthopedic companies participate where handheld instrumentation is integrated into procedure-specific implant or reconstruction workflows.

Scale creates advantages in contracting and availability. STERIS, for example, markets more than 17,000 surgical-instrument products across V. Mueller, Snowden-Pencer, and Genesis portfolios, while Medline’s König range alone includes more than 17,000 reusable patterns. Sklar reports more than 19,000 surgical-instrument patterns across multiple clinical specialties. These portfolio depths demonstrate why SKU rationalization and cross-referencing are increasingly important to hospital buyers.

Smaller companies remain competitive because surgical instrumentation retains significant surgeon-level preference. A focused supplier can win share by creating superior forceps geometry, a specialized retractor, a lighter needle holder, a unique minimally invasive design, or an instrument that solves a persistent workflow problem.

Market share through 2035 will therefore be determined by a combination of product quality, specialty depth, price architecture, health-system contracting, repair capabilities, sterile-processing support, supply reliability, clinician loyalty, and lifecycle economics.

 

Recent Developments

Recent developments indicate that competitive strategy in surgical instrumentation is shifting from standalone instruments toward broader perioperative and sterile-processing ecosystems.

Aspen Surgical has expanded its perioperative capabilities through acquisitions. During 2025 it announced the addition of Cygnus Medical and Flagship Surgical, strengthening infection-control, instrument-care, and operating-room workflow capabilities. It subsequently acquired Ruhof Healthcare, adding enzymatic detergents, cleaning-verification systems, reprocessing products, and instrument-refurbishment capabilities. The combination is strategically relevant because instrument manufacturers increasingly benefit from controlling more of the lifecycle surrounding reusable devices rather than relying solely on replacement sales.

Regulatory requirements also entered a new phase in February 2026, when FDA’s Quality Management System Regulation became effective and incorporated ISO 13485:2016 into the U.S. quality-system framework. This increases the importance of documented manufacturing controls, supplier oversight, complaint systems, risk management, and quality consistency across global instrument supply chains.

Sterile-processing performance continues to receive stronger attention because reusable instruments must be thoroughly cleaned and appropriately sterilized between uses. FDA guidance emphasizes that reprocessing is labor intensive, multistep, and device specific. Manufacturers are consequently placing greater emphasis on cleanability, validated instructions, tray organization, repair, and products that reduce unnecessary processing complexity.

At the same time, robotics is reshaping—but not eliminating—the manual instrument opportunity. In July 2026, Johnson & Johnson received U.S. FDA marketing authorization for its Ottava robotic surgical system for selected general upper-abdominal procedures, increasing competition in robotic soft-tissue surgery. As robotic platforms expand, conventional manual instrument manufacturers will increasingly focus on open surgery, hybrid workflows, access and exposure, emergency conversion, specialty procedures, and minimally invasive manual instruments that complement rather than compete directly with robotics.

The broader procedural environment remains supportive. Medical-device manufacturers have continued to report resilient demand for elective and non-urgent surgical procedures, particularly among older adults. This reinforces the expectation that instrument utilization and replacement should remain structurally healthy despite hospital cost pressure.

Another important development is the growing use of digital instrument identification, workflow analytics, computer vision, and automated tray-support technologies. These capabilities are still emerging relative to the established manual-instrument business, but they could alter procurement by giving hospitals more accurate information on utilization, tray composition, instrument condition, and sterile-processing workload. The long-term competitive advantage may therefore move toward manufacturers that can connect physical instruments with lifecycle data.

 

Conclusion

The U.S. Handheld Surgical Instruments Market Size & Share is projected to increase from approximately USD 2.45 billion in 2025 to USD 5.05 billion by 2035, representing a CAGR of 7.50% during 2026–2035. Historical market value is estimated to have increased from approximately USD 1.86 billion in 2021 to USD 2.30 billion in 2024 as surgical volumes normalized, hospitals refreshed aging instrument inventories, ambulatory surgery expanded, and specialty procedures recovered.

The market should not be viewed as a commodity pool of forceps and scissors. Its commercial structure ranges from low-cost standardized instruments to highly specialized cardiovascular, neuro, orthopedic, ophthalmic, reconstructive, and minimally invasive products where surgeon preference, craftsmanship, instrument balance, tip geometry, materials, and reliability create significant differentiation.

Reusable instruments will remain dominant through 2035 because their economics are attractive in high-volume environments. However, sterile single-use products will gain share where reprocessing cost, infection-control requirements, instrument availability, or procedure frequency makes disposability economically rational. The most sophisticated U.S. health systems will increasingly adopt a deliberate hybrid model rather than choosing one approach universally.

Hospital purchasing behavior will also evolve. Value-analysis committees, perioperative executives, sterile-processing leaders, supply-chain teams, and surgeons will increasingly evaluate instrument portfolios through total lifecycle cost. Acquisition price will remain important, but repair frequency, processing labor, tray utilization, replacement rates, inventory availability, clinician satisfaction, and procedure interruptions will influence vendor selection more heavily.

Product opportunity will remain strongest across forceps and graspers, retractors, scissors, clamps, needle holders, specialty microsurgical instruments, orthopedic hand instruments, and minimally invasive manual designs. General surgery will remain the largest application, while orthopedic, spine, neurosurgical, cardiovascular, and other specialty categories provide attractive premium-value opportunities.

Regionally, the South will remain the largest U.S. market, supported by Texas, Florida, North Carolina, Georgia, Virginia, and Tennessee. The West is expected to grow fastest, driven by California and rapidly expanding Arizona, Nevada, Colorado, and Utah. The Northeast will retain high premium instrument intensity because of specialist and academic surgical concentration, while the Midwest will remain a stable, high-utilization market anchored by Illinois, Ohio, Michigan, and Minnesota.

For clients evaluating the U.S. handheld surgical instruments industry, the critical question is no longer simply how many instruments hospitals purchase. The more valuable questions are which surgical specialties will generate replacement and premiumization, where outpatient migration changes instrument economics, which products can defend pricing against private-label alternatives, and how manufacturers can reduce the lifecycle cost of instrument ownership.

Companies that combine durable product quality with specialty expertise, reliable supply, repair capability, instrument-set optimization, sterile-processing support, regulatory discipline, and enterprise contracting will be positioned to capture disproportionate value from the next decade of U.S. surgical procedure growth.

 

TABLE OF CONTENT

1. U.S. Handheld Surgical Instruments Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Market Sizing, Bottom-Up & Top-Down Analytical Frameworks
1.3.6. Forecasting Models, Triangulation & Sensitivity Analysis
1.3.7. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Historical Period, Base Year and Forecast Period
1.6. Market Ecosystem Overview
1.7. Market Inclusion and Exclusion Criteria
1.7.1. Manual Handheld Surgical Instruments Included
1.7.2. Reusable Instruments Included
1.7.3. Sterile Single-Use Instruments Included
1.7.4. Powered Surgical Instruments Excluded
1.7.5. Robotic Instruments and Systems Excluded
1.7.6. Endoscopic Capital Equipment Excluded
1.8. Stakeholder Analysis
1.8.1. Handheld Surgical Instrument Manufacturers
1.8.2. Raw Material and Component Suppliers
1.8.3. Contract Manufacturing and OEM Suppliers
1.8.4. Hospitals and Integrated Delivery Networks
1.8.5. Ambulatory Surgery Centers
1.8.6. Specialty Surgical Centers and Physician Practices
1.8.7. Sterile Processing Departments
1.8.8. Group Purchasing Organizations
1.8.9. Medical-Surgical Distributors
1.8.10. Surgeons and Perioperative Clinical Decision-Makers
1.8.11. FDA, CMS and Other Regulatory Stakeholders

What this section provides: This section defines the U.S. handheld surgical instruments market boundary, covered products, exclusions, research methodology, sizing framework, assumptions, and stakeholder ecosystem so clients can clearly understand how the market is measured and validated.

2. U.S. Handheld Surgical Instruments Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. U.S. Market Size, 2021–2035 (US$ Billion)
2.8. Market Growth Rate Analysis, 2026–2035 (%)
2.9. Highest-Revenue Product Categories
2.10. Fastest-Growing Surgical Applications
2.11. Reusable vs. Single-Use Market Outlook
2.12. Hospital vs. ASC Demand Outlook
2.13. Regional Opportunity Snapshot
2.14. High-Growth Opportunity Areas
2.15. Key Strategic Takeaways for Market Participants

What this section provides: This section gives decision-makers an executive-level view of market size, historical development, forecast growth, segment leadership, care-setting demand, regional positioning, and priority commercial opportunities.

3. U.S. Handheld Surgical Instruments Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Large and Resilient U.S. Surgical Procedure Volume
3.1.2. Aging Population and Rising Surgical Intervention Rates
3.1.3. Expansion of Ambulatory and Outpatient Surgery
3.1.4. Increasing Orthopedic and Spine Procedure Burden
3.1.5. Growing Cancer Surgery Volumes
3.1.6. Instrument Replacement and Replenishment Cycles
3.1.7. Rising Demand for Specialty and Precision Instruments
3.1.8. Surgical Tray Standardization and Optimization
3.1.9. Sterile Processing and Infection-Control Requirements
3.1.10. Growth in Minimally Invasive Manual Instrumentation

3.2. Restraints and Their Impact Analysis
3.2.1. Pricing Pressure on Standard Surgical Instruments
3.2.2. GPO and IDN Contracting Pressure
3.2.3. Long Replacement Cycles for Premium Reusable Instruments
3.2.4. Availability of Low-Cost and Private-Label Products
3.2.5. Hospital Cost-Containment Initiatives
3.2.6. Sterile Processing Labor and Reprocessing Costs
3.2.7. Sustainability Concerns Surrounding Disposable Instruments

3.3. Opportunities and Their Impact Analysis
3.3.1. Expansion of Ambulatory Surgery Centers
3.3.2. Premium Microsurgical and Specialty Instrumentation
3.3.3. Single-Use Sterile Surgical Instrument Adoption
3.3.4. Instrument Repair and Lifecycle Management Services
3.3.5. Digital Instrument Identification and Traceability
3.3.6. Surgical Tray Rationalization Programs
3.3.7. Minimally Invasive and Small-Incision Instrument Designs
3.3.8. Enterprise-Level Hospital Instrument Standardization
3.3.9. U.S. Domestic Manufacturing and Supply-Chain Localization

3.4. Challenges and Their Impact Analysis
3.4.1. SKU Fragmentation and Surgeon Preference Variability
3.4.2. Instrument Loss, Damage and Misplacement
3.4.3. Maintaining Performance Across Repeated Sterilization Cycles
3.4.4. Commodity Competition and Margin Compression
3.4.5. Raw Material and Manufacturing Cost Volatility
3.4.6. Supply-Chain Dependence on International Manufacturing Hubs

3.5. Patent & Innovation Analysis, 2021–2025
3.6. Surgical Workflow Economics Analysis
3.7. Instrument Lifecycle Cost Analysis
3.8. Hospital Procurement Behavior Analysis
3.9. ASC Procurement Economics Analysis
3.10. Sterile Processing Department Workflow Analysis
3.11. Surgical Tray Utilization and Rationalization Analysis
3.12. Surgeon Preference and Product Standardization Analysis

What this section provides: This section evaluates the clinical, operational, demographic and procurement forces influencing handheld surgical instrument demand and helps clients identify growth catalysts, market constraints, lifecycle economics, and execution risks.

4. U.S. Handheld Surgical Instruments Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal

4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitutes
4.2.5. Competitive Rivalry

4.3. Pricing Trend Analysis by Region, 2025–2035
4.4. Average Selling Price Trend by Instrument Category
4.5. Premium vs. Standard Instrument Pricing Analysis
4.6. Value Chain Analysis
4.7. Supply Chain Analysis
4.8. Stainless Steel and Specialty Alloy Supply Assessment
4.9. U.S. Import Dependence and Manufacturing Footprint Analysis
4.10. Contract Manufacturing and OEM Landscape
4.11. Surgical Instrument Repair and Refurbishment Ecosystem
4.12. Impact of Digital Instrument Identification and Traceability
4.13. Instrument Tracking and Sterile Processing Digitalization
4.14. Ergonomic and Materials Innovation Landscape
4.15. FDA Regulatory Framework Analysis
4.16. FDA Reusable Medical Device Reprocessing Requirements
4.17. FDA Quality Management System Regulation Impact
4.18. CMS Surgical Procedure Reimbursement and Facility Economics
4.19. Hospital Value Analysis Committee Decision Framework
4.20. Group Purchasing Organization Influence Analysis
4.21. Import/Export Restrictions & Tariff Impact
4.22. U.S. Supply-Chain Localization Trends
4.23. Environmental Sustainability and Reusable-vs.-Disposable Analysis
4.24. Impact of Escalating Geopolitical and Trade Tensions

What this section provides: This section provides a complete assessment of the industry’s regulatory, pricing, supply-chain, procurement, manufacturing, reprocessing, technology, sustainability, and competitive environment.

5. U.S. Handheld Surgical Instruments Market – By Product Type

5.1. Overview
5.1.1. Segment Share Analysis, By Product Type, 2025 & 2035 (%)

5.2. Forceps and Graspers
5.2.1. Tissue Forceps
5.2.2. Dressing Forceps
5.2.3. Dissecting Forceps
5.2.4. Hemostatic Forceps
5.2.5. Vascular Forceps
5.2.6. Atraumatic Forceps
5.2.7. Microsurgical Forceps
5.2.8. Specialty Surgical Graspers

5.3. Retractors
5.3.1. Handheld Retractors
5.3.2. Self-Retaining Retractors
5.3.3. Abdominal Retractors
5.3.4. Orthopedic and Spine Retractors
5.3.5. Cardiovascular and Thoracic Retractors
5.3.6. Neurosurgical Retractors
5.3.7. Specialty Minimally Invasive Retractors

5.4. Surgical Scissors
5.4.1. Operating Scissors
5.4.2. Dissecting Scissors
5.4.3. Suture Scissors
5.4.4. Vascular Scissors
5.4.5. Microsurgical Scissors
5.4.6. Ophthalmic Scissors
5.4.7. Specialty Angled Scissors

5.5. Clamps and Occluding Instruments
5.5.1. Hemostatic Clamps
5.5.2. Vascular Clamps
5.5.3. Bulldog Clamps
5.5.4. Bowel and Intestinal Clamps
5.5.5. Towel Clamps
5.5.6. Specialty Occluding Instruments

5.6. Scalpels and Surgical Knives
5.6.1. Reusable Scalpel Handles
5.6.2. Disposable Scalpels
5.6.3. Surgical Blades
5.6.4. Specialty Surgical Knives
5.6.5. Microsurgical and Ophthalmic Knives

5.7. Needle Holders
5.7.1. Standard Needle Holders
5.7.2. Tungsten-Carbide Needle Holders
5.7.3. Vascular Needle Holders
5.7.4. Microsurgical Needle Holders
5.7.5. Specialty Suturing Instruments

5.8. Dilators, Probes, Curettes and Dissectors
5.8.1. Surgical Dilators
5.8.2. Surgical Probes
5.8.3. Curettes
5.8.4. Dissectors
5.8.5. Elevators
5.8.6. Osteotomes
5.8.7. Rongeurs
5.8.8. Hooks and Spatulas

5.9. Other Handheld Surgical Instruments

What this section provides: This section determines which handheld instrument categories generate the greatest revenue, replacement demand and premiumization opportunity and identifies product areas expected to outperform through 2035.

6. U.S. Handheld Surgical Instruments Market – By Application

6.1. Overview
6.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)

6.2. General and Abdominal Surgery
6.2.1. Gastrointestinal Surgery
6.2.2. Colorectal Surgery
6.2.3. Hernia Repair
6.2.4. Hepatobiliary Surgery
6.2.5. Bariatric Surgery
6.2.6. Breast Surgery
6.2.7. Endocrine Surgery

6.3. Orthopedic and Spine Surgery
6.3.1. Joint Reconstruction
6.3.2. Trauma and Fracture Surgery
6.3.3. Sports Medicine
6.3.4. Spine Surgery
6.3.5. Extremity Surgery
6.3.6. Bone and Soft-Tissue Procedures

6.4. Cardiovascular and Thoracic Surgery
6.4.1. Cardiac Surgery
6.4.2. Vascular Surgery
6.4.3. Thoracic Surgery
6.4.4. Cardiothoracic Minimally Invasive Surgery
6.4.5. Transplant-Related Procedures

6.5. Neurosurgery
6.5.1. Cranial Surgery
6.5.2. Neuro-Oncology Surgery
6.5.3. Cerebrovascular Surgery
6.5.4. Functional Neurosurgery
6.5.5. Microsurgical Procedures

6.6. Obstetrics and Gynecology
6.6.1. Cesarean Delivery
6.6.2. Hysterectomy
6.6.3. Gynecologic Oncology
6.6.4. Pelvic Surgery
6.6.5. Fertility and Reproductive Procedures

6.7. Urology
6.7.1. Prostate Surgery
6.7.2. Kidney Surgery
6.7.3. Bladder Surgery
6.7.4. Urologic Oncology
6.7.5. Reconstructive Urology

6.8. Ophthalmology
6.8.1. Cataract and Anterior Segment Surgery
6.8.2. Retinal Surgery
6.8.3. Corneal Surgery
6.8.4. Ophthalmic Microsurgery

6.9. ENT Surgery
6.9.1. Otologic Surgery
6.9.2. Rhinology and Sinus Surgery
6.9.3. Head and Neck Surgery
6.9.4. Laryngology Procedures

6.10. Plastic, Reconstructive and Maxillofacial Surgery
6.10.1. Plastic Surgery
6.10.2. Reconstructive Surgery
6.10.3. Craniofacial Surgery
6.10.4. Maxillofacial Surgery

6.11. Other Surgical Applications

What this section provides: This section analyzes handheld instrument demand by surgical specialty and helps clients identify procedure areas with the strongest instrument intensity, premium product requirements and growth prospects.

7. U.S. Handheld Surgical Instruments Market – By Usability

7.1. Overview
7.1.1. Segment Share Analysis, By Usability, 2025 & 2035 (%)

7.2. Reusable Handheld Surgical Instruments
7.2.1. Standard Reusable Instruments
7.2.2. Premium Specialty Reusable Instruments
7.2.3. Microsurgical Reusable Instruments
7.2.4. Procedure-Specific Reusable Instrument Sets
7.2.5. Reusable Instrument Repair and Refurbishment Requirements

7.3. Single-Use Handheld Surgical Instruments
7.3.1. Sterile Disposable Forceps and Graspers
7.3.2. Disposable Scissors
7.3.3. Disposable Scalpels and Knives
7.3.4. Disposable Retractors
7.3.5. Procedure-Specific Single-Use Instruments
7.3.6. Sterile Surgical Instrument Kits

7.4. Reusable vs. Single-Use Total Cost of Ownership Analysis
7.5. Reprocessing Cost Comparison
7.6. Infection-Control Considerations
7.7. Sustainability and Medical-Waste Considerations

What this section provides: This section compares reusable and single-use instrument economics, reprocessing requirements, infection-control considerations, lifecycle costs, and future adoption patterns.

8. U.S. Handheld Surgical Instruments Market – By Material & Construction

8.1. Overview
8.1.1. Segment Share Analysis, By Material & Construction, 2025 & 2035 (%)

8.2. Stainless Steel Instruments
8.2.1. Standard Surgical-Grade Stainless Steel
8.2.2. High-Performance Stainless Steel Instruments
8.2.3. Satin and Non-Reflective Finish Instruments
8.2.4. Passivated and Corrosion-Resistant Instruments

8.3. Titanium Instruments
8.3.1. Microsurgical Titanium Instruments
8.3.2. Neurosurgical Titanium Instruments
8.3.3. Cardiovascular Titanium Instruments
8.3.4. Ophthalmic Titanium Instruments

8.4. Tungsten-Carbide and Premium Insert Instruments
8.4.1. Tungsten-Carbide Needle Holders
8.4.2. Tungsten-Carbide Surgical Scissors
8.4.3. Specialty Grip and Cutting Instruments

8.5. Polymer and Composite Instruments
8.5.1. Single-Use Polymer Instruments
8.5.2. Composite Handle Instruments
8.5.3. Hybrid Metal-Polymer Designs

8.6. Other Specialty Materials and Coatings

What this section provides: This section evaluates the materials, surface technologies and construction methods influencing instrument durability, weight, performance, reprocessing capability, average selling price, and specialty adoption.

9. U.S. Handheld Surgical Instruments Market – By End User

9.1. Overview
9.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)

9.2. Hospitals and Integrated Health Systems
9.2.1. Academic Medical Centers
9.2.2. Tertiary and Quaternary Hospitals
9.2.3. Community Hospitals
9.2.4. Trauma Centers
9.2.5. Integrated Delivery Networks

9.3. Ambulatory Surgery Centers
9.3.1. Multispecialty ASCs
9.3.2. Orthopedic and Spine ASCs
9.3.3. Ophthalmology ASCs
9.3.4. Gastrointestinal and General Surgery ASCs
9.3.5. Other Specialty ASCs

9.4. Specialty Surgical Centers and Physician Practices
9.4.1. Ophthalmology Centers
9.4.2. Plastic and Reconstructive Surgery Centers
9.4.3. ENT Practices
9.4.4. Dermatologic Surgery Centers
9.4.5. Urology Practices
9.4.6. Dental and Maxillofacial Centers

9.5. Government, Veterans and Military Healthcare Facilities
9.5.1. Veterans Health Administration Facilities
9.5.2. Department of Defense Healthcare Facilities
9.5.3. Federal and State Government Hospitals

9.6. Other End Users

What this section provides: This section identifies the U.S. healthcare settings generating handheld surgical instrument purchases and evaluates differences in product mix, purchasing criteria, instrument utilization, reprocessing capacity and replacement behavior.

10. U.S. Handheld Surgical Instruments Market – By Geography
10.1. Introduction

10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Surgical Procedure Volume Analysis
10.1.4. Regional Hospital and ASC Infrastructure Analysis
10.1.5. Regional Surgical Specialty Mix Analysis
10.1.6. Regional Instrument Replacement and Reprocessing Dynamics
10.1.7. Regional Hospital and IDN Procurement Dynamics
10.1.8. Regional GPO and Distribution Landscape
10.1.9. Regional Competitive Intensity Analysis

10.2. West Region

10.2.1. Regional Overview & Trends
10.2.2. West Region Handheld Surgical Instrument Key Manufacturers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.2.9. California

10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.2.10. Washington

10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.2.11. Arizona

10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.2.12. Colorado

10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.2.13. Oregon

10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.2.14. Utah

10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.2.15. Nevada

10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.2.16. New Mexico

10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.2.17. Idaho

10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.2.18. Montana

10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.2.19. Wyoming

10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.2.20. Alaska

10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.2.21. Hawaii

10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.3. Northeast Region

10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Handheld Surgical Instrument Key Manufacturers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.3.9. New York

10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.3.10. Massachusetts

10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.3.11. New Jersey

10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.3.12. Pennsylvania

10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.3.13. Connecticut

10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.3.14. Maine

10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.3.15. Vermont

10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.3.16. New Hampshire

10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.3.17. Rhode Island

10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.3.18. Delaware

10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4. South Region

10.4.1. Regional Overview & Trends
10.4.2. South Region Handheld Surgical Instrument Key Manufacturers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4.9. Texas

10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4.10. Florida

10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4.11. Georgia

10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4.12. North Carolina

10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4.13. Tennessee

10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4.14. South Carolina

10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4.15. Alabama

10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4.16. Mississippi

10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4.17. Louisiana

10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4.18. Arkansas

10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4.19. Kentucky

10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4.20. Oklahoma

10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4.21. Virginia

10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4.22. Maryland

10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4.23. West Virginia

10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.5. Midwest Region

10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Handheld Surgical Instrument Key Manufacturers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.5.9. Illinois

10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.5.10. Ohio

10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.5.11. Michigan

10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.5.12. Minnesota

10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.5.13. Indiana

10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.5.14. Wisconsin

10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.5.15. Missouri

10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.5.16. Iowa

10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.5.17. Kansas

10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.5.18. Nebraska

10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.5.19. North Dakota

10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.5.20. South Dakota

10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By Usability, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By Material & Construction, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

What this section provides: This section delivers detailed regional and state-level analysis across all 50 states, enabling clients to identify surgical procedure hubs, hospital and ASC demand centers, instrument replacement opportunities, procurement hotspots, and priority commercial geographies.

11. U.S. Handheld Surgical Instruments Market: Competitive Landscape & Company Profiles

11.1. Competitive Landscape Overview
11.2. Market Share Analysis, 2025
11.3. Market Concentration Analysis
11.4. Company Positioning Matrix
11.4.1. Leaders
11.4.2. Challengers
11.4.3. Specialty Innovators
11.4.4. Emerging and Niche Players
11.5. Product Portfolio Benchmarking
11.6. Specialty Coverage Benchmarking
11.7. Reusable Instrument Portfolio Benchmarking
11.8. Single-Use Instrument Portfolio Benchmarking
11.9. Pricing and Value Proposition Benchmarking
11.10. Repair and Instrument Lifecycle Service Benchmarking
11.11. U.S. Distribution and GPO Positioning
11.12. Strategic Initiatives, Partnerships, M&A and Portfolio Expansion

11.13. Company Profiles

11.13.1. B. Braun / Aesculap
11.13.2. STERIS – V. Mueller and Snowden-Pencer
11.13.3. Integra LifeSciences / Integra Miltex
11.13.4. Aspen Surgical / Symmetry Surgical
11.13.5. Sklar Corporation
11.13.6. KLS Martin Group
11.13.7. Medline Industries
11.13.8. Teleflex Incorporated
11.13.9. Stryker Corporation
11.13.10. CONMED Corporation
11.13.11. Arthrex
11.13.12. CooperSurgical
11.13.13. Scanlan International
11.13.14. Thompson Surgical Instruments
11.13.15. STILLE
11.13.16. gSource
11.13.17. Millennium Surgical
11.13.18. Boss Instruments
11.13.19. Surgical Holdings
11.13.20. Surtex Instruments
11.13.21. BD
11.13.22. Cardinal Health
11.13.23. GerMedUSA
11.13.24. Novo Surgical
11.13.25. Marina Medical Instruments

11.14. Company Profile Coverage Framework
11.14.1. Company Overview
11.14.2. U.S. Handheld Surgical Instrument Portfolio
11.14.3. Key Product Categories and Surgical Specialties
11.14.4. U.S. Market Strategy
11.14.5. Distribution and Procurement Positioning
11.14.6. Manufacturing and Supply-Chain Footprint
11.14.7. Instrument Repair and Lifecycle Services
11.14.8. Innovation and Product Development Strategy
11.14.9. Partnerships, Acquisitions and Strategic Initiatives
11.14.10. Recent Developments

What this section provides: This section gives clients competitor benchmarking, market-share visibility, specialty portfolio positioning, pricing and service differentiation, distribution intelligence, and strategic profiles of major companies competing in the U.S. handheld surgical instruments market.

12. U.S. Handheld Surgical Instruments Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario

12.2. Emerging and Disruptive Trends Impact
12.2.1. Advanced Metallurgy and Lightweight Instrument Design
12.2.2. Ergonomic Instrument Engineering
12.2.3. Growth of Single-Use Sterile Surgical Instruments
12.2.4. Digital Instrument Identification and Traceability
12.2.5. RFID and Data-Matrix Instrument Tracking
12.2.6. AI-Assisted Surgical Tray Optimization
12.2.7. Automated Sterile Processing Workflow Support
12.2.8. Minimally Invasive Handheld Instrument Innovation
12.2.9. Instrument Repair, Refurbishment and Circular-Economy Models
12.2.10. U.S. Manufacturing Reshoring and Supply-Chain Localization

12.3. Future Reusable vs. Single-Use Market Structure
12.4. Future Hospital vs. ASC Demand Mix
12.5. Surgical Tray Rationalization Outlook
12.6. Surgeon Preference vs. Enterprise Standardization Outlook
12.7. Emerging Business Models
12.8. Service-Based Instrument Lifecycle Management Opportunities
12.9. Opportunities for Startups and Existing Players
12.10. M&A and Consolidation Outlook
12.11. Investment Prioritization Matrix
12.12. High-Potential Product Opportunity Matrix
12.13. High-Potential Application Opportunity Matrix
12.14. High-Potential State Opportunity Matrix

What this section provides: This section prepares clients for future changes in instrument design, materials, reprocessing, traceability, procurement, care-setting migration, supply chains and competitive structure through 2035.

13. U.S. Handheld Surgical Instruments Market: Strategic Recommendations

13.1. Recommendations for Handheld Surgical Instrument Manufacturers
13.2. Recommendations for Hospitals and Integrated Health Systems
13.3. Recommendations for Ambulatory Surgery Centers
13.4. Recommendations for Sterile Processing Departments
13.5. Recommendations for Investors and Private Equity Firms
13.6. Recommendations for Distributors and GPO Channel Partners
13.7. Recommendations for OEM and Contract Manufacturers
13.8. Recommendations for New Entrants and Specialty Instrument Startups
13.9. Go-to-Market Strategy Considerations
13.10. Product Positioning Strategy
13.11. Specialty Portfolio Expansion Strategy
13.12. Reusable vs. Single-Use Portfolio Strategy
13.13. Pricing and Contracting Strategy
13.14. Hospital IDN Conversion Strategy
13.15. ASC Market Entry Strategy
13.16. Instrument Repair and Lifecycle Service Strategy
13.17. Geographic Expansion Priorities
13.18. M&A and Partnership Strategy
13.19. Supply-Chain Resilience Recommendations

What this section provides: This section translates market intelligence into actionable recommendations for product strategy, hospital and ASC penetration, pricing, contracting, specialty expansion, lifecycle services, investment decisions, and competitive differentiation.

14. U.S. Handheld Surgical Instruments Market: Disclaimer

14.1. Scope Limitation
14.2. Market Definition Limitation
14.3. Data Use Limitation
14.4. Market Estimation Limitation
14.5. Forecasting Limitation
14.6. State-Level Estimation Limitation
14.7. Company and Competitive Data Limitation
14.8. Legal Disclaimer
14.9. Third-Party Data Disclaimer

What this section provides: This section clarifies the report’s scope boundaries, market-estimation assumptions, state-level modeling limitations, forecast uncertainties, legal conditions, and data-use terms.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Handheld Surgical Instruments Market: Market Definition and Scope
TABLE 3: U.S. Handheld Surgical Instruments Market: Research Methodology Framework
TABLE 4: U.S. Handheld Surgical Instruments Market: Key Assumptions
TABLE 5: U.S. Handheld Surgical Instruments Market: Market Ecosystem Overview
TABLE 6: U.S. Handheld Surgical Instruments Market: Stakeholder Analysis
TABLE 7: U.S. Handheld Surgical Instruments Market: Inclusion and Exclusion Criteria
TABLE 8: U.S. Handheld Surgical Instruments Market: Executive Summary Snapshot, 2025
TABLE 9: U.S. Handheld Surgical Instruments Market: Analyst Viewpoint Summary
TABLE 10: U.S. Handheld Surgical Instruments Market: Market Attractiveness Index
TABLE 11: U.S. Handheld Surgical Instruments Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 12: U.S. Handheld Surgical Instruments Market: Base Year Market Positioning, 2025
TABLE 13: U.S. Handheld Surgical Instruments Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 14: U.S. Handheld Surgical Instruments Market: High-Growth Opportunity Areas
TABLE 15: U.S. Handheld Surgical Instruments Market: Drivers; Impact Analysis
TABLE 16: U.S. Handheld Surgical Instruments Market: Restraints; Impact Analysis
TABLE 17: U.S. Handheld Surgical Instruments Market: Opportunities; Impact Analysis
TABLE 18: U.S. Handheld Surgical Instruments Market: Challenges; Impact Analysis
TABLE 19: U.S. Handheld Surgical Instruments Market: Patent & Innovation Analysis, 2021–2025
TABLE 20: U.S. Handheld Surgical Instruments Market: Surgical Workflow Economics Matrix
TABLE 21: U.S. Handheld Surgical Instruments Market: Instrument Lifecycle Cost Analysis
TABLE 22: U.S. Handheld Surgical Instruments Market: Hospital Procurement Behavior Matrix
TABLE 23: U.S. Handheld Surgical Instruments Market: ASC Procurement Economics Analysis
TABLE 24: U.S. Handheld Surgical Instruments Market: Sterile Processing Workflow Analysis
TABLE 25: U.S. Handheld Surgical Instruments Market: Surgical Tray Rationalization Matrix
TABLE 26: U.S. Handheld Surgical Instruments Market: PESTEL Analysis
TABLE 27: U.S. Handheld Surgical Instruments Market: Porter’s Five Forces Analysis
TABLE 28: U.S. Handheld Surgical Instruments Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 29: U.S. Handheld Surgical Instruments Market: Average Selling Price Trend by Instrument Type
TABLE 30: U.S. Handheld Surgical Instruments Market: Value Chain Analysis
TABLE 31: U.S. Handheld Surgical Instruments Market: Supply Chain Analysis
TABLE 32: U.S. Handheld Surgical Instruments Market: Raw Material and Specialty Alloy Supply Assessment
TABLE 33: U.S. Handheld Surgical Instruments Market: U.S. Import Dependence and Manufacturing Footprint
TABLE 34: U.S. Handheld Surgical Instruments Market: Surgical Instrument Repair and Refurbishment Ecosystem
TABLE 35: U.S. Handheld Surgical Instruments Market: Digital Identification and Instrument Tracking Landscape
TABLE 36: U.S. Handheld Surgical Instruments Market: FDA Regulatory Framework Analysis
TABLE 37: U.S. Handheld Surgical Instruments Market: Reusable Device Reprocessing Requirements
TABLE 38: U.S. Handheld Surgical Instruments Market: Hospital Value Analysis Committee Decision Framework
TABLE 39: U.S. Handheld Surgical Instruments Market: Import, Tariff and Geopolitical Risk Analysis
TABLE 40: U.S. Handheld Surgical Instruments Market: Product Type Snapshot, 2025
TABLE 41: Segment Dashboard; Definition and Scope, by Product Type
TABLE 42: U.S. Handheld Surgical Instruments Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 43: U.S. Handheld Surgical Instruments Market: Segment Share Analysis, by Product Type, 2025 & 2035 (%)
TABLE 44: Forceps and Graspers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 45: Retractors Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 46: Surgical Scissors Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 47: Clamps and Occluding Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 48: Scalpels and Surgical Knives Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 49: Needle Holders, Dilators, Probes, Curettes and Other Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 50: U.S. Handheld Surgical Instruments Market: Application Snapshot, 2025
TABLE 51: Segment Dashboard; Definition and Scope, by Application
TABLE 52: U.S. Handheld Surgical Instruments Market, by Application, 2021–2035 (US$ Billion)
TABLE 53: U.S. Handheld Surgical Instruments Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 54: General and Abdominal Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 55: Orthopedic and Spine Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 56: Cardiovascular and Thoracic Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 57: Neurosurgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 58: Obstetrics and Gynecology Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 59: Urology Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 60: Ophthalmology Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 61: ENT, Plastic, Reconstructive and Other Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 62: U.S. Handheld Surgical Instruments Market: Usability Snapshot, 2025
TABLE 63: Segment Dashboard; Definition and Scope, by Usability
TABLE 64: U.S. Handheld Surgical Instruments Market, by Usability, 2021–2035 (US$ Billion)
TABLE 65: U.S. Handheld Surgical Instruments Market: Segment Share Analysis, by Usability, 2025 & 2035 (%)
TABLE 66: Reusable Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 67: Single-Use Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 68: Reusable vs. Single-Use Total Cost of Ownership Analysis
TABLE 69: U.S. Handheld Surgical Instruments Market: Material & Construction Snapshot, 2025
TABLE 70: Segment Dashboard; Definition and Scope, by Material & Construction
TABLE 71: U.S. Handheld Surgical Instruments Market, by Material & Construction, 2021–2035 (US$ Billion)
TABLE 72: U.S. Handheld Surgical Instruments Market: Segment Share Analysis, by Material & Construction, 2025 & 2035 (%)
TABLE 73: Stainless Steel Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: Titanium Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 75: Tungsten-Carbide, Polymer, Composite and Other Specialty Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: U.S. Handheld Surgical Instruments Market: End User Snapshot, 2025
TABLE 77: Segment Dashboard; Definition and Scope, by End User
TABLE 78: U.S. Handheld Surgical Instruments Market, by End User, 2021–2035 (US$ Billion)
TABLE 79: U.S. Handheld Surgical Instruments Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 80: Hospitals and Integrated Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 81: Ambulatory Surgery Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 82: Specialty Surgical Centers, Physician Practices, Government and Other End Users Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 83: U.S. Handheld Surgical Instruments Market: Regional Snapshot, 2025
TABLE 84: Segment Dashboard; Definition and Scope, by Geography
TABLE 85: U.S. Handheld Surgical Instruments Market, by Region, 2021–2035 (US$ Billion)
TABLE 86: U.S. Handheld Surgical Instruments Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 87: U.S. Handheld Surgical Instruments Market: Regional Surgical Procedure and Healthcare Infrastructure Analysis
TABLE 88: West Region U.S. Handheld Surgical Instruments Market: Regional Overview and Trends
TABLE 89: West Region U.S. Handheld Surgical Instruments Market, by State, 2021–2035 (US$ Billion)
TABLE 90: California Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 91: Washington Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 92: Arizona Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 93: Colorado Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 94: Oregon Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 95: Utah Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 96: Nevada Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 97: New Mexico Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 98: Idaho Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 99: Montana Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 100: Wyoming Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 101: Alaska Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 102: Hawaii Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 103: Northeast Region U.S. Handheld Surgical Instruments Market: Regional Overview and Trends
TABLE 104: Northeast Region U.S. Handheld Surgical Instruments Market, by State, 2021–2035 (US$ Billion)
TABLE 105: New York Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 106: Massachusetts Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 107: New Jersey Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 108: Pennsylvania Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 109: Connecticut Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 110: Maine Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 111: Vermont Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 112: New Hampshire Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 113: Rhode Island Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 114: Delaware Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 115: South Region U.S. Handheld Surgical Instruments Market: Regional Overview and Trends
TABLE 116: South Region U.S. Handheld Surgical Instruments Market, by State, 2021–2035 (US$ Billion)
TABLE 117: Texas Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 118: Florida Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 119: Georgia Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 120: North Carolina Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 121: Tennessee Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 122: South Carolina Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 123: Alabama Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 124: Mississippi Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 125: Louisiana Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 126: Arkansas Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 127: Kentucky Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 128: Oklahoma Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 129: Virginia Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 130: Maryland Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 131: West Virginia Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 132: Midwest Region U.S. Handheld Surgical Instruments Market: Regional Overview and Trends
TABLE 133: Midwest Region U.S. Handheld Surgical Instruments Market, by State, 2021–2035 (US$ Billion)
TABLE 134: Illinois Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 135: Ohio Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 136: Michigan Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 137: Minnesota Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 138: Indiana Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 139: Wisconsin Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 140: Missouri Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 141: Iowa Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 142: Kansas Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 143: Nebraska Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 144: North Dakota Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 145: South Dakota Handheld Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 146: U.S. Handheld Surgical Instruments Market: Competitive Landscape Snapshot, 2025
TABLE 147: U.S. Handheld Surgical Instruments Market: Key Company Market Share Analysis, 2025
TABLE 148: U.S. Handheld Surgical Instruments Market: Company Positioning Matrix
TABLE 149: U.S. Handheld Surgical Instruments Market: Product Portfolio Benchmarking of Key Players
TABLE 150: U.S. Handheld Surgical Instruments Market: Pricing, Repair and Lifecycle Service Benchmarking
TABLE 151: U.S. Handheld Surgical Instruments Market: Strategic Developments, Partnerships, M&A and Portfolio Expansion
TABLE 152: B. Braun / Aesculap: Company Profile
TABLE 153: STERIS – V. Mueller and Snowden-Pencer: Company Profile
TABLE 154: Integra LifeSciences / Integra Miltex: Company Profile
TABLE 155: Aspen Surgical / Symmetry Surgical: Company Profile
TABLE 156: Sklar Corporation: Company Profile
TABLE 157: KLS Martin Group: Company Profile
TABLE 158: Medline Industries: Company Profile
TABLE 159: Teleflex Incorporated: Company Profile
TABLE 160: Stryker Corporation: Company Profile
TABLE 161: CONMED Corporation: Company Profile
TABLE 162: Arthrex: Company Profile
TABLE 163: CooperSurgical: Company Profile
TABLE 164: Scanlan International: Company Profile
TABLE 165: Thompson Surgical Instruments: Company Profile
TABLE 166: STILLE: Company Profile
TABLE 167: gSource: Company Profile
TABLE 168: Millennium Surgical: Company Profile
TABLE 169: Boss Instruments: Company Profile
TABLE 170: Surgical Holdings: Company Profile
TABLE 171: Surtex Instruments: Company Profile
TABLE 172: BD: Company Profile
TABLE 173: Cardinal Health: Company Profile
TABLE 174: GerMedUSA: Company Profile
TABLE 175: Novo Surgical: Company Profile
TABLE 176: Marina Medical Instruments: Company Profile
TABLE 177: U.S. Handheld Surgical Instruments Market: Future Market Scenario Analysis, 2026–2035
TABLE 178: U.S. Handheld Surgical Instruments Market: Emerging and Disruptive Trends Impact Matrix
TABLE 179: U.S. Handheld Surgical Instruments Market: Reusable vs. Single-Use Future Market Structure
TABLE 180: U.S. Handheld Surgical Instruments Market: Hospital vs. ASC Future Demand Mix
TABLE 181: U.S. Handheld Surgical Instruments Market: Surgical Tray Rationalization Outlook
TABLE 182: U.S. Handheld Surgical Instruments Market: Emerging Business Models
TABLE 183: U.S. Handheld Surgical Instruments Market: Investment Prioritization Matrix
TABLE 184: U.S. Handheld Surgical Instruments Market: High-Potential Product, Application and Geography Opportunity Matrix
TABLE 185: U.S. Handheld Surgical Instruments Market: Strategic Recommendations for Manufacturers
TABLE 186: U.S. Handheld Surgical Instruments Market: Strategic Recommendations for Hospitals and Health Systems
TABLE 187: U.S. Handheld Surgical Instruments Market: Strategic Recommendations for Ambulatory Surgery Centers
TABLE 188: U.S. Handheld Surgical Instruments Market: Strategic Recommendations for Sterile Processing Departments
TABLE 189: U.S. Handheld Surgical Instruments Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 190: U.S. Handheld Surgical Instruments Market: Strategic Recommendations for Distributors and GPO Partners
TABLE 191: U.S. Handheld Surgical Instruments Market: Go-to-Market Strategy Considerations
TABLE 192: U.S. Handheld Surgical Instruments Market: Product Positioning and Portfolio Expansion Guidance
TABLE 193: U.S. Handheld Surgical Instruments Market: Geographic Expansion and Supply-Chain Strategy
TABLE 194: U.S. Handheld Surgical Instruments Market: Scope Limitation
TABLE 195: U.S. Handheld Surgical Instruments Market: Data Use Limitation
TABLE 196: U.S. Handheld Surgical Instruments Market: Forecasting and State-Level Estimation Limitation
TABLE 197: U.S. Handheld Surgical Instruments Market: Legal Disclaimer
TABLE 198: U.S. Handheld Surgical Instruments Market: Third-Party Data Disclaimer

List of Figures

FIGURE 1: U.S. Handheld Surgical Instruments Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: U.S. Handheld Surgical Instruments Market Ecosystem
FIGURE 4: Stakeholder Ecosystem
FIGURE 5: U.S. Handheld Surgical Instruments Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 6: U.S. Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 7: U.S. Handheld Surgical Instruments Market Year-wise Growth Curve, 2021–2035
FIGURE 8: Market Attractiveness Analysis
FIGURE 9: U.S. Handheld Surgical Instruments Market Dynamics
FIGURE 10: Innovation & Patent Landscape, 2021–2025
FIGURE 11: Surgical Workflow Economics Framework
FIGURE 12: Instrument Lifecycle Cost Framework
FIGURE 13: Hospital Procurement Decision Framework
FIGURE 14: ASC Procurement Economics Framework
FIGURE 15: Surgical Tray Rationalization Framework
FIGURE 16: PESTEL Analysis
FIGURE 17: Porter’s Five Forces Analysis
FIGURE 18: Value Chain and Supply Chain Analysis
FIGURE 19: Product Type Segment Market Share Analysis, 2025 & 2035
FIGURE 20: Product Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 21: Forceps and Graspers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 22: Retractors Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 23: Surgical Scissors Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 24: Clamps and Occluding Instruments Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 25: Scalpels and Surgical Knives Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 26: Needle Holders and Other Handheld Instruments Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 27: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 28: Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 29: General and Abdominal Surgery Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 30: Orthopedic and Spine Surgery Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 31: Cardiovascular and Thoracic Surgery Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 32: Neurosurgery Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 33: Obstetrics and Gynecology Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 34: Urology Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: Ophthalmology Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: ENT, Plastic, Reconstructive and Other Surgery Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 37: Usability Segment Market Share Analysis, 2025 & 2035
FIGURE 38: Usability Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 39: Reusable Handheld Surgical Instruments Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 40: Single-Use Handheld Surgical Instruments Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 41: Reusable vs. Single-Use Total Cost of Ownership Framework
FIGURE 42: Material & Construction Segment Market Share Analysis, 2025 & 2035
FIGURE 43: Material & Construction Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 44: Stainless Steel Instruments Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 45: Titanium Instruments Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 46: Premium Alloy, Polymer and Composite Instrument Opportunity Analysis
FIGURE 47: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 48: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 49: Hospitals and Integrated Health Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 50: Ambulatory Surgery Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 51: Specialty Surgical Centers, Physician Practices and Other End Users Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 52: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 53: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 54: West Region U.S. Handheld Surgical Instruments Market Share and Leading Players, 2025
FIGURE 55: West Region Market Share Analysis by State, 2025
FIGURE 56: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 57: California Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 58: Washington Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 59: Arizona Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 60: Colorado Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 61: Oregon Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 62: Utah Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 63: Nevada Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 64: New Mexico Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 65: Idaho Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 66: Montana Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 67: Wyoming Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 68: Alaska Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 69: Hawaii Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 70: Northeast Region U.S. Handheld Surgical Instruments Market Share and Leading Players, 2025
FIGURE 71: Northeast Region Market Share Analysis by State, 2025
FIGURE 72: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 73: New York Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 74: Massachusetts Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 75: New Jersey Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 76: Pennsylvania Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 77: Connecticut Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 78: Maine Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 79: Vermont Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 80: New Hampshire Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 81: Rhode Island Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 82: Delaware Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 83: South Region U.S. Handheld Surgical Instruments Market Share and Leading Players, 2025
FIGURE 84: South Region Market Share Analysis by State, 2025
FIGURE 85: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 86: Texas Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 87: Florida Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 88: Georgia Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 89: North Carolina Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 90: Tennessee Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 91: South Carolina Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 92: Alabama Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 93: Mississippi Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 94: Louisiana Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 95: Arkansas Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 96: Kentucky Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 97: Oklahoma Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 98: Virginia Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 99: Maryland Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 100: West Virginia Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 101: Midwest Region U.S. Handheld Surgical Instruments Market Share and Leading Players, 2025
FIGURE 102: Midwest Region Market Share Analysis by State, 2025
FIGURE 103: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 104: Illinois Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 105: Ohio Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 106: Michigan Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 107: Minnesota Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 108: Indiana Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 109: Wisconsin Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 110: Missouri Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 111: Iowa Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 112: Kansas Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 113: Nebraska Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 114: North Dakota Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 115: South Dakota Handheld Surgical Instruments Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 116: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 117: Company Positioning Matrix
FIGURE 118: Key Player Product Portfolio Benchmarking
FIGURE 119: Pricing, Repair and Lifecycle Service Competitive Benchmarking
FIGURE 120: Strategic Developments, Partnerships, M&A and Portfolio Expansion
FIGURE 121: U.S. Handheld Surgical Instruments Innovation Roadmap
FIGURE 122: Future Market Scenario Analysis, 2026–2035
FIGURE 123: Emerging and Disruptive Trends Impact Matrix
FIGURE 124: Reusable vs. Single-Use Adoption Roadmap
FIGURE 125: Digital Instrument Identification and Traceability Roadmap
FIGURE 126: Surgical Tray Optimization and Sterile Processing Opportunity Map
FIGURE 127: Investment Prioritization Matrix
FIGURE 128: High-Potential Product, Application and State Opportunity Matrix
FIGURE 129: Strategic Growth Roadmap for U.S. Handheld Surgical Instrument Companies
FIGURE 130: Go-to-Market, Product Positioning and Portfolio Expansion Framework
FIGURE 131: Hospital and ASC Market Penetration Strategy Framework
FIGURE 132: Geographic Expansion and Supply-Chain Resilience Framework
FIGURE 133: Report Scope and Disclaimer Framework